these results are consistent with the hypothesis that beta-adrenergic blocking compounds enhance the responsivity of the pituitary gland to agents that permit gh release by inhibiting hypothalamic somatostatin secretion or action .
C0020663
hypothalamic
C0037659
somatostatin